SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The SRPX2 Gene NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the SRPX2 gene associated with a complex neurodevelopmental disorder. This sophisticated testing methodology provides critical insights for patients and families affected by Rolandic epilepsy, intellectual disability, and speech coordination challenges.
What Does This Test Measure?
Our advanced NGS technology comprehensively analyzes the SRPX2 gene to detect:
- Point mutations and single nucleotide variants
- Small insertions and deletions (indels)
- Copy number variations affecting gene function
- Pathogenic variants linked to neurological symptoms
- Inheritance patterns for family risk assessment
Who Should Consider This Genetic Test?
This specialized genetic testing is recommended for individuals presenting with:
Primary Symptoms and Clinical Indications
- Children with Rolandic epilepsy (benign childhood epilepsy with centrotemporal spikes)
- Individuals experiencing developmental speech dyspraxia (verbal apraxia)
- Patients with unexplained intellectual disability or cognitive impairment
- Family history of similar neurological conditions
- Unexplained seizure disorders in childhood
- Speech coordination difficulties without clear etiology
- Developmental delays affecting language acquisition
Clinical Benefits of SRPX2 Genetic Testing
Diagnostic Clarity and Treatment Planning
Obtaining a definitive genetic diagnosis through SRPX2 testing provides numerous clinical advantages:
- Accurate Diagnosis: Confirms the genetic basis of neurological symptoms
- Personalized Treatment: Enables targeted therapeutic interventions
- Family Planning: Provides crucial information for genetic counseling
- Prognostic Insights: Helps predict disease progression and outcomes
- Early Intervention: Facilitates timely support services and therapies
Understanding Your Test Results
Interpretation and Next Steps
Our comprehensive genetic counseling ensures you fully understand your test results:
- Positive Result: Identifies a pathogenic SRPX2 mutation, confirming diagnosis
- Negative Result: No mutation detected, though clinical evaluation continues
- Variant of Uncertain Significance: Requires additional family studies
- Carrier Status: Important for family members and future generations
Test Information and Pricing
| Test Component | Details |
|---|---|
| Test Name | SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Pre-Test Requirements
Before scheduling your SRPX2 genetic test, please ensure:
- Complete clinical history documentation
- Genetic counseling session to create family pedigree chart
- Discussion of testing implications with healthcare provider
- Understanding of potential outcomes and next steps
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures you receive comprehensive care regardless of your location.
Take Control of Your Neurological Health
Don’t let unexplained neurological symptoms remain a mystery. Our SRPX2 genetic testing provides the answers you need for proper diagnosis and treatment planning. With our discounted price of $500 USD and comprehensive genetic counseling services, you can make informed decisions about your health and future.
Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and accessing targeted treatment options.
